ROCKVILLE, Md., June 3, 2019 /PRNewswire/ -- USP released new and revised standards to help ensure the quality of compounded medicines. The updates pertain to the USP General Chapters on compounding ...
The organization’s goal in this area is to provide suitable methods and reference standards that can help the industry and regulators ensure cannabis quality The U.S. Pharmacopeia (USP) has decided to ...
This report provides plans for the USP Council's work in the 2010-2015. This articles contains online bonus material. USP s compendia and reference materials are made available through decisions of ...
The U.S. Pharmacopeia (USP), the world's only nongovernmental pharmacopeia, establishes state-of-the-art standards to ensure the quality of medicines, dietary supplements, and other healthcare ...
The United States Pharmacopeial Convention, the organization hired by Medicare to develop a formulary for the prescription drug benefit, on Monday released its proposed list of prescription drug ...
Sterile compounding practices are increasingly under scrutiny. State pharmacy boards, in tandem with national efforts by accreditation organizations, are raising the stakes on this critical component ...
On Nov. 1, the new U.S. Pharmacopoeia standards on sterile and nonsterile compounding will be implemented. Here’s what leaders need to know about USP 795 and USP 797: a. Nonpreserved aqueous dosage ...
The United States Pharmacopeia (USP) Convention’s Chapter 800, “Hazardous Drugs — Handling in Healthcare Settings,” goes into effect Dec. 1. The new standards provide detailed specifications for the ...
The US Pharmacopeia (USP), a global independent scientific organization, has identified the need for guidelines and analytical procedures regarding quality assessments for messenger (mRNA) vaccines ...
On June 1, 2019, the United States Pharmacopeia (“USP”) published the final revisions to its pharmaceutical sterile compounding standards (“chapter <797>”). Chapter <797> sets forth standards for the ...
The USP 800 requires ASCs and other healthcare organizations to be compliant with a number of medication handling standards regarding receiving, transporting, storing, dispensing and disposing of them ...
The U.S. Food and Drug Administration today alerted health care professionals to a change in heparin manufacturing that is expected to decrease the potency of the common anti-clotting drug. To ensure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results